Micromedic Reports Successful Interim Results from Bladder Cancer Clinical Study

 

Micromedic Technologies achieved successful interim results in a blinded bladder cancer clinical trial with its CellDetect® technology. Micromedic is continuing the trial with the goal of developing a kit for monitoring the recurrence of bladder cancer. This study is being conducted at seven medical centers and is expected to be completed in the fourth quarter of 2014.

Link to complete article

More News/Information
© Micromedic Technologies Ltd. site mapcontact
 
Site by Site2goal | Design Studio Michal Lehavi